| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/2015 | US20150052635 Gene encoding enzyme that reduces position 24 of steroid skeleton and plant in which expression level of the gene is lowered |
| 02/19/2015 | US20150052634 Transgenic plants having altered biomass composition |
| 02/19/2015 | US20150052633 Mutation of the ear motif of class ii hd-zip polypeptides |
| 02/19/2015 | US20150052632 Method for enhancing drought tolerance in plants |
| 02/19/2015 | US20150052630 Methods and Compositions for Obtaining Useful Plant Traits |
| 02/19/2015 | US20150052629 Fungal Resistant Plants Expressing OCP3 |
| 02/19/2015 | US20150052628 Tomato hybrid ex01420200 and parent lines thereof |
| 02/19/2015 | US20150052624 Genetically modified rat models for pain |
| 02/19/2015 | US20150052623 Genetically modified rat models for pharmacokinetics |
| 02/19/2015 | US20150051389 Selective antisense compounds and uses thereof |
| 02/19/2015 | US20150051267 BICISTRONIC GENE TRANSFER TOOLS FOR DELIVERY OF miRNAS AND PROTEIN CODING SEQUENCES |
| 02/19/2015 | US20150051266 Chimeric antigen receptors targeting b-cell maturation antigen |
| 02/19/2015 | US20150051264 Inhibitors of nox4 expression and /or nox4 function and their use in the prevention and treatment of nerve injury and/or neuropathic pain |
| 02/19/2015 | US20150051263 Identification of a jak2 mutation in polycythemia vera |
| 02/19/2015 | US20150051117 Assembly of Nucleic Acid Sequences in Emulsions |
| 02/19/2015 | US20150051116 Next-generation sequencing libraries |
| 02/19/2015 | US20150051113 Nucleotide analogs |
| 02/19/2015 | US20150051112 Anti-sigmas for programmable transcriptional regulation |
| 02/19/2015 | US20150051099 Methods of constructing small rna libraries and their use for expression profiling of target rnas |
| 02/19/2015 | US20150051088 Next-generation sequencing libraries |
| 02/19/2015 | US20150050740 Method for introducing an exogenous dna by overcoming the restriction modification barrier of a target bacterium |
| 02/19/2015 | US20150050739 Recombination system |
| 02/19/2015 | US20150050738 Compositions and methods for modulating rna |
| 02/19/2015 | US20150050713 Technology for the Preparation of Microparticles |
| 02/19/2015 | US20150050708 Microorganisms and methods for producing butadiene and related compounds by formate assimilation |
| 02/19/2015 | US20150050704 Biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs |
| 02/19/2015 | US20150050699 RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX |
| 02/19/2015 | US20150050698 Development of nucleic acid gel matrix for cell-free protein synthesis of cell nucleus replicate, and method for producing same |
| 02/19/2015 | US20150050697 Nucleotide analogs |
| 02/19/2015 | US20150050696 Cloning Method |
| 02/19/2015 | US20150050691 Method for preparing mutant escherichia coli capable of simultaneously utilizing glucose and xylose |
| 02/19/2015 | US20150050670 Combinatorial gamma 9 delta 2 t cell receptor chain exchange |
| 02/19/2015 | US20150050658 Gene shuffling methods |
| 02/19/2015 | US20150050360 Pharmaceutical compositions for treating cancer |
| 02/19/2015 | US20150050347 Reverse micelle system comprising nucleic acids and use thereof |
| 02/19/2015 | US20150050341 Methods and compositions for rnai-based cancer treatment |
| 02/19/2015 | US20150050328 Methods for treating eye disorders |
| 02/19/2015 | US20150050288 Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3 |
| 02/19/2015 | US20150050265 Anti-mcpip therapies for ocular neovascularization |
| 02/18/2015 | EP2837696A2 Method for preparing a nucleic acid with high precision used in detecting a nucleic acid with a nucleic acid polymerase |
| 02/18/2015 | EP2837695A1 Nucleic acid quantification method, detection probe, detection probe set, and nucleic acid detection method |
| 02/18/2015 | EP2837694A1 Method of diagnosing cancer based on MED15 and/or MED12 |
| 02/18/2015 | EP2837688A1 Method for producing amino acid |
| 02/18/2015 | EP2837685A1 Anti-fgfr2 antibody |
| 02/18/2015 | EP2837684A1 Method for detecting target nucleic acid using molecular beacon-type probe |
| 02/18/2015 | EP2837623A1 Novel 1-substituted indazole derivative |
| 02/18/2015 | EP2837389A1 Medicinal composition for treating infarction |
| 02/18/2015 | EP2837387A1 Anticancer agent |
| 02/18/2015 | EP2837383A1 Immunity-inducing agent |
| 02/18/2015 | EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 02/18/2015 | EP2836609A1 Compositions and methods for quantifying a nucleic acid sequence in a sample |
| 02/18/2015 | EP2836599A1 Production of omega-3 long chain polyunsaturated fatty acids |
| 02/18/2015 | EP2836598A1 Gene expresssion from mitotically stable episomes |
| 02/18/2015 | EP2836597A1 Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof |
| 02/18/2015 | EP2836596A2 Compositions for controlling varroa mites in bees |
| 02/18/2015 | EP2836595A2 Compositions and methods for inhibiting expression of the alas1 gene |
| 02/18/2015 | EP2836589A1 Antibiotic sensitive bacillus strains having antimicrobial effect against e. coli and clostridium perfringens and having high sporulation capacity |
| 02/18/2015 | EP2836584A1 Method for digesting biological cells |
| 02/18/2015 | EP2836514A1 Tiki inhibitors |
| 02/18/2015 | EP2836511A1 Polypeptide useful in adoptive cell therapy |
| 02/18/2015 | EP2836507A2 Sortase- modified vhh domains and uses thereof |
| 02/18/2015 | EP2836501A1 Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells |
| 02/18/2015 | EP2836239A1 Chimeric antigen receptors targeting b-cell maturation antigen |
| 02/18/2015 | EP2836220A1 Methods for bladder cancer therapy using baculoviral vectors |
| 02/18/2015 | EP2836219A1 Methods for the treatment of nonalcoholic steatohepatitis |
| 02/17/2015 | US8957289 Maize hybrid X08C961 |
| 02/17/2015 | US8957288 Tomato Line FDS 17-APER |
| 02/17/2015 | US8957287 Tomato line PSQ-9Z09042 |
| 02/17/2015 | US8957285 Soybean variety XB03N13 |
| 02/17/2015 | US8957283 Alfalfa variety 09W08PY |
| 02/17/2015 | US8957282 Yield and stress tolerance in transgenic plants IV |
| 02/17/2015 | US8957280 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
| 02/17/2015 | US8957251 Pactamycin analogs and methods of making thereof |
| 02/17/2015 | US8957223 Ligand-conjugated monomers |
| 02/17/2015 | US8957199 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus |
| 02/17/2015 | US8957198 Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna |
| 02/17/2015 | US8957196 Vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same |
| 02/17/2015 | US8957194 1B20 PCSK9 antagonists |
| 02/17/2015 | US8957193 Polynucleotides encoding anti-CD40 antibodies |
| 02/17/2015 | US8957192 Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 |
| 02/17/2015 | US8957044 Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM) |
| 02/17/2015 | US8957043 Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2 |
| 02/17/2015 | US8957042 Cancer treatment targeting non-coding RNA overexpression |
| 02/17/2015 | US8957041 Short interfering ribonucleic acid (siRNA) for oral administration |
| 02/17/2015 | US8957040 Selective reduction of allelic variants |
| 02/17/2015 | US8957039 Methods and compositions for the diagnosis and prognosis of cervical intraepithelial neoplasia and cervical cancer |
| 02/17/2015 | US8957038 Treatment of neurological disorders |
| 02/17/2015 | US8957036 Targeted delivery of glycine receptors to excitable cells |
| 02/17/2015 | US8956878 Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy |
| 02/17/2015 | US8956873 Host cells with artificial endosymbionts |
| 02/17/2015 | US8956872 QTL controlling sclerotinia stem rot resistance in soybean |
| 02/17/2015 | US8956864 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells |
| 02/17/2015 | US8956863 Agents from cells |
| 02/17/2015 | US8956857 Three-component biosensors for detecting macromolecules and other analytes |
| 02/17/2015 | US8956851 Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors |
| 02/17/2015 | US8956849 Compositions and methods of enhancing immune responses to Eimeria |
| 02/17/2015 | US8956847 Fusion proteins |
| 02/17/2015 | US8956843 Perhydrolase variant providing improved specific activity |
| 02/17/2015 | US8956842 Paenibacillus sp. HPL-3 strain producing xylanase having heat-resistance, a wide range of optimum pH and high activity, a novel xylanase separated from the strain, and a method for mass-production of the same using the transformant originated from the strain |
| 02/17/2015 | US8956838 Carboxyl esterase polypeptides |